Search results for query: *

  1. S

    Treatment Prospects: Vagus Nerve Stimulation

    I tend to automatically view pharm therapies in a cost/benefit light. Benefit = efficacy; cost = side effects. When I first read about vagus nerve stimulation, it sounded very safe and side-effect free. However, there are risks associated with the procedure itself (rare) and more troubling, a...
  2. S

    Lidocaine and Dexamethasone Perfusion

    This is odd. I was seen by Mayo clinic's ENT dep't within the first 3 months of onset. I was only seen by a resident. Tinnitus alone, absent other, more serious issues (I also had fairly intense ear pain at the time) does NOT warrant an internal, up-referral to one of the permanent staff ENT...
  3. S

    AM-101 TACTT1 Results Released

    As several other posters have noted, AM-101 appears to be shaping up to be an underwhelming treatment. I can envision a downside to AM-101's entrance into the marketplace. Let's assume AM-101 passes all of the necessary regulatory, investor, and internal hurdles. When a distressed patient...
  4. S

    AM-101 TACTT1 Results Released

    Yes, this about sums it up I would say. I agree with you.
  5. S

    Everyone Has Tinnitus

    If everyone has tinnitus, why have structural brain changes associated with tinnitus been identified (changes not observed in non-tinnitus population)? http://www.ncbi.nlm.nih.gov/pubmed/19413945 http://www.ata.org/sites/ata.org/files/pdf/Van_Dijk_Functional_Magnetic_Resonance_Imaging_12_2009.pdf